equityflowunderstand the flow and follow it
EquityFlow › Companies › VALANX Biotech

VALANX Biotech

Biotech · Graz, AT

Austrian biotech (Graz) developing antibody-drug conjugates using its GoldenSite site-specific conjugation platform.

In the network

Shares the most investors with (number = shared investors):
Valanx 4

Funding history

DateRoundAmount
Mar 2026Funding round
Austria's VALANX Biotech raised EUR 3M, including new backers Foundation Fournier-Majoie and Fujifilm, to advance its ADC for metastatic triple-negative breast cancer.
$3.5M
Nov 2023Growth
Austrian synthetic-biology firm VALANX Biotech raised EUR2.3M in a growth round led by SkyGene to develop its protein conjugation platform.
$2.5M

Investors

Tap an investor to see what else they have backed.

FUJIFILM CorporationFoundation Fournier-MajoieSOSVSkyGenetecnet equityxista science ventures

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in AT

Invisible-Light Labsfonio.aiFiber ElementsEconetixTACEOenspiredrefurbedVitrealabGropyusAnother EarthsequestraStreamUnlimited

Other companies at Unknown stage

&Charge/dev/agents123-Transporter123fahrschule13Hz1Global1Komma5°1MT Nation1Password20Face21.co2NA FISH
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.